[Activity Report] HGPI Manager Mr. Shunichiro Kurita Serves on Committee for Enacting a Local Regulation for Dementia in Urayasu City (September, 2021)
date : 4/28/2022
Tags: Dementia
Health and Global Policy Institute (HGPI) Manager Mr. Shunichiro Kurita served as a member of the “Committee for Enacting a Local Regulation for Dementia in Urayasu City” organized by Urayasu City in Chiba Prefecture.
The Committee met a total of three times to discuss the content of a local regulation for Urayasu City based on the voices of people living with dementia collected at meetings and workshops, and in surveys. Discussion points included items to be emphasized when enacting a local regulation for dementia as well as each member’s opinions regarding recommendations from the Secretariat.
At the meetings, Mr. Kurita shared opinions based on the content of policy recommendations presented by HGPI titled, “Steps Toward Regulations for Dementia That Achieve Citizen-Centered Dementia Policy” as well as on discussions he previously presented on the subject.
The “Urayasu City Basic Ordinance on Dementia Coexistence” was approved and enacted by the Urayasu City Council on March 11, 2022 and is scheduled to go into effect on July 1, 2022. (Please visit the Urayasu City website for details. Please note the Urayasu City website is available in Japanese only.)
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Recommendations] Creating a Long-Term Care System for the Era of Healthy Longevity –Five Discussion Points Revealed by Current Circumstances and Three Perspectives For The Future (March 31, 2022)
- [Event Report] Rethinking Social Security: Ensuring an Ideal Balance between Health Insurance Benefits and Premiums – A Multistakeholder Conversation on Japan’s Universal Healthcare System (November 5, 2019)
- [Research Report] Public Opinion Survey on Priorities for Policies Related to Children’s Health (January 17, 2022)
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)


